Sigmapharm Laboratories, LLC FDA Inspection Record

FEI 3005444934 · Inspections, Form 483s, warning letters and import refusals

Sigmapharm Laboratories, LLC is an FDA-registered facility (FEI 3005444934) located in Bensalem, PA, US. Registered operations: ANALYSIS; API MANUFACTURE; MANUFACTURE. RegDataLab tracks 12 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Dec 17, 2025: Voluntary Action Indicated (VAI)
Inspections on record
12 (7 VAI, 5 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
4, latest Sep 21, 2021

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 12 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Dec 17, 2025Voluntary Action Indicated (VAI)Extent of discrepancy, failure investigations (21 CFR 211.192)
Feb 13, 2023No Action Indicated (NAI)No citations listed
Dec 7, 2021No Action Indicated (NAI)No citations listed
Jun 13, 2018No Action Indicated (NAI)No citations listed
Jun 19, 2017Voluntary Action Indicated (VAI)Review of representative number of batches (21 CFR 211.180(e)(1))
Jun 23, 2015No Action Indicated (NAI)No citations listed
Nov 19, 2014Voluntary Action Indicated (VAI)Approve or reject procedures or specs (21 CFR 211.22(c))
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Maintenance of Complaint File (21 CFR 211.198(b))
Control procedures to monitor and validate performance (21 CFR 211.110(a))
and 2 more
Mar 20, 2014Voluntary Action Indicated (VAI)No citations listed
Aug 13, 2013Voluntary Action Indicated (VAI)Failure to review ADE information (21 CFR 314.80(b))
Incomplete periodic safety report (21 CFR 314.80(c)(2)(ii)(A))
Dec 22, 2011Voluntary Action Indicated (VAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Sep 21, 2021Class IID-0898-2021Sodium Phenylbutyrate Powder, 250 Grams, Rx Only, packaged in 500 cc HDPE bottles and 53…
Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing.
Aug 13, 2021Class IID-0766-2021Sodium Phenylbutyrate POWDER, 250 grams bottle, Rx Only, Sigmapharm Laboratories, LLC…
Failed Impurities Specifications: Out of Specification impurity results obtained during routine testing.
Apr 19, 2021Class IIID-0379-2021Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC… and 1 more product
Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry…
Apr 22, 2014Class IID-1344-2014Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and…
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a…

FDA record score

10 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

10 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIDec 17, 20256 x 16
Inspection classified VAIJun 19, 20176 x 0.251.5
Class II recall D-0898-2021, this FEI as the recalling firmSep 21, 20214 x 0.251
Class II recall D-0766-2021, this FEI as the recalling firmAug 13, 20214 x 0.251
Inspection classified VAINov 19, 201410 years or older, so it adds no points0
Class II recall D-1344-2014, this FEI as the recalling firmApr 22, 201410 years or older, so it adds no points0
Inspection classified VAIMar 20, 201410 years or older, so it adds no points0
Inspection classified VAIAug 13, 201310 years or older, so it adds no points0
Inspection classified VAIDec 22, 201110 years or older, so it adds no points0
Inspection classified VAIMay 25, 201110 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Sigmapharm Laboratories, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Sigmapharm Laboratories, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
SigmaPharm Laboratories LLC
Location
Bensalem, PA (US)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS; API MANUFACTURE; MANUFACTURE
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.